Back to list

DNAnexus

Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data.
Discovery Tools (Healthcare) 📍 San Francisco, CA Founded 2009
Current Valuation
$620M
as of 2022-Q1
PRIVATE
Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data.

Company Profile

Founded
2009
HQ
San Francisco, CA
Employees
284
Total Raised
$478.73M
Last Round
Series I — $200M (Mar 2022)
IPO Status
private

Fundraising Status

Series I · $200M · 4y 5mo ago
privateTotal raised $478.73M

Secondary Market

Implied price / share
$1.05
Last round price / share
$0.61
vs last round
+72.1%
Last round price vs secondary price
Last round vs current secondary price per share$0.61Last round$1.05Current
Secondary price return by period
Secondary market period returns3-month0.0%6-month0.0%1-year+453%All-time+72.1%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series I$200MMar 2022$620M
MedicalBioinformaticsBiotechnologyCloud Computing
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q1. Refreshed quarterly.